AMAT
33
3
APH
53
3
LB
16
9
GE
60
5
F
38
4
FITB
36
3
DTE
49
16
ALL
37
3
MET
58
2
PFE
37
4
SIG
52
5
HPQ
55
3
NEM
30
2
PLD
35
5
ESS
44
5
HRB
40
3
ADBE
50
3
CHD
34
7
ZTS
38
4
MHK
25
5
AMAT
33
3
APH
53
3
LB
16
9
GE
60
5
F
38
4
FITB
36
3
DTE
49
16
ALL
37
3
MET
58
2
PFE
37
4
SIG
52
5
HPQ
55
3
NEM
30
2
PLD
35
5
ESS
44
5
HRB
40
3
ADBE
50
3
CHD
34
7
ZTS
38
4
MHK
25
5
Financhill
Back

PROCEPT BioRobotics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
5

PRCT
PROCEPT BioRobotics

Last Price:
$81.28
Seasonality Move:
4.99%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
5
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy, Sell or Hold?

  • The current PROCEPT BioRobotics [PRCT] share price is $81.17. The Score for PRCT is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • PRCT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRCT Stock Price Chart

What is PROCEPT BioRobotics's stock price today?

  • The PROCEPT BioRobotics share price today is $81.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRCT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

PRCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.95 Sell
Relative Strength Index (14 RSI): 33.77 Sell
Chaikin Money Flow: 279963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.99 - 97.01) Sell
Bollinger Bands (100): (69.12 - 92.36) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

PRCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.47 Sell
20-day SMA: 91.97 Sell
50-day SMA: 87.74 Sell
200-day SMA: 69.98 Buy
8-day EMA: 85.71 Sell
20-day EMA: 89.2 Sell
50-day EMA: 87.62 Sell
200-day EMA: 72.08 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.46 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

PROCEPT BioRobotics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):